Seok-Yun Lee
Overview
Explore the profile of Seok-Yun Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rogers S, Gross M, Ermis E, Cosgun G, Baumert B, Mader T, et al.
BMC Neurol
. 2024 Nov;
24(1):462.
PMID: 39587462
Background: 90% of glioblastomas (GBM) relapse within two years of diagnosis. In contrast to the initial setting, there is no standard management for recurrent disease and options include hypofractionated stereotactic...
2.
Otth M, Weiser A, Lee S, Rudolf von Rohr L, Heesen P, Guerreiro Stucklin A, et al.
J Adolesc Young Adult Oncol
. 2024 Aug;
PMID: 39178158
Medulloblastoma is the most frequent high-grade tumor of the central nervous system in children but accounts for less than 1% of these tumors in adults. Adolescent and young adult (AYA)...
3.
Lee S, Lomax N, Berkmann S, Vollmer K, Riesterer O, Bodis S, et al.
Strahlenther Onkol
. 2021 Aug;
197(12):1143-1147.
PMID: 34459938
A 70-year old male with stage I large cell neuroendocrine carcinoma (LCNEC) of the lung underwent resection of a metachronous 5 cm brain metastasis and received postoperative hypofractionated stereotactic radiotherapy...
4.
Akhoundova D, Hiltbrunner S, Mader C, Forster R, Kraft J, Schwanhausser B, et al.
Clin Nucl Med
. 2019 Dec;
45(2):113-117.
PMID: 31876831
Purpose: To evaluate whether F-fluoroethyltyrosine (FET) PET can discriminate progression from pseudoprogression of brain metastases in patients with non-small cell lung cancer undergoing immunotherapy and radiotherapy to the brain. Methods:...
5.
Lacour M, Hiltbrunner S, Lee S, Soltermann A, Rushing E, Soldini D, et al.
Clin Lung Cancer
. 2019 Jul;
20(5):391-396.
PMID: 31262689
Background: Despite recent studies, the effect of chemotherapy on programmed death-ligand 1 (PD-L1) expression remains controversial. In this study, we investigated whether PD-L1 expression is affected by platinum-based chemotherapy. Furthermore,...